• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.

作者信息

Le Meur Yannick, Borrows Richard, Pescovitz Mark D, Budde Klemens, Grinyo Josep, Bloom Roy, Gaston Robert, Walker Rowan G, Kuypers Dirk, van Gelder Teun, Kiberd Bryce

机构信息

Nephrology Department, University Hospital La Cavale Blanche, Université de Brest, France.

出版信息

Transplant Rev (Orlando). 2011 Apr;25(2):58-64. doi: 10.1016/j.trre.2011.01.002. Epub 2011 Mar 30.

DOI:10.1016/j.trre.2011.01.002
PMID:21454067
Abstract
摘要

相似文献

1
Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.肾移植中霉酚酸酯的治疗药物监测：移植学会共识会议报告
Transplant Rev (Orlando). 2011 Apr;25(2):58-64. doi: 10.1016/j.trre.2011.01.002. Epub 2011 Mar 30.
2
Therapeutic drug monitoring of mycophenolates: why make simple things complicated?霉酚酸酯的治疗药物监测：为何要把简单的事情复杂化？
Transplant Rev (Orlando). 2011 Apr;25(2):45-6. doi: 10.1016/j.trre.2011.01.003.
3
Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.霉酚酸的药代动力学/药效学关系及排斥反应抑制情况提示肾移植中霉酚酸酯剂量治疗监测的机会。
Clin Biochem. 1998 Jul;31(5):329-33. doi: 10.1016/s0009-9120(98)00056-3.
4
Therapeutic monitoring of mycophenolic acid. A consensus panel report.霉酚酸的治疗监测。一份共识小组报告。
Clin Biochem. 1998 Jul;31(5):317-22. doi: 10.1016/s0009-9120(98)00040-x.
5
Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?霉酚酸酯的治疗药物浓度监测：是否合理？
Transplant Proc. 2001 Aug;33(5):2778-9. doi: 10.1016/s0041-1345(01)02188-1.
6
Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?霉酚酸酯监测：是否有证据表明其能改善治疗结果？
Clin Pharmacol Ther. 2011 Aug;90(2):204-6. doi: 10.1038/clpt.2011.95.
7
Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.霉酚酸的分析、药代动力学及治疗药物监测
Clin Biochem. 1998 Jul;31(5):323-8. doi: 10.1016/s0009-9120(98)00050-2.
8
Therapeutic drug monitoring for mycophenolic acid is value for (little) money.霉酚酸的治疗药物监测性价比（很低）。
Clin Pharmacol Ther. 2011 Aug;90(2):203-4. doi: 10.1038/clpt.2011.96.
9
Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report.肝、胸、胰腺和小肠移植中的霉酚酸监测：共识报告。
Transplant Rev (Orlando). 2011 Apr;25(2):65-77. doi: 10.1016/j.trre.2010.12.001. Epub 2011 Mar 30.
10
Therapeutic monitoring of mycophenolate mofetil.霉酚酸酯的治疗监测
Clin J Am Soc Nephrol. 2007 Jan;2(1):184-91. doi: 10.2215/CJN.02860806. Epub 2006 Nov 8.

引用本文的文献

1
Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients.通过治疗药物监测证实，新肾移植受者中减少剂量的霉酚酸酯固定剂量安全性良好。
Kidney Res Clin Pract. 2025 Jan;44(1):200-209. doi: 10.23876/j.krcp.23.274. Epub 2024 Oct 24.
2
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis.霉酚酸的治疗药物监测与狼疮肾炎的临床结局：系统评价和荟萃分析。
Lupus Sci Med. 2024 Jan 17;11(1):e001093. doi: 10.1136/lupus-2023-001093.
3
Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument.
基于 AGREE II 工具的治疗药物监测指南的现状和质量。
Clin Pharmacokinet. 2023 Sep;62(9):1201-1217. doi: 10.1007/s40262-023-01283-x. Epub 2023 Jul 25.
4
Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities.年龄与稳定的黑人和白人肾移植受者他克莫司和吗替麦考酚酸药代动力学的关系：对健康不平等的影响。
Clin Transl Sci. 2023 May;16(5):861-871. doi: 10.1111/cts.13495. Epub 2023 Apr 13.
5
Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients.ABCC2 单倍型与稳定期肾移植受者麦考酚酸药代动力学的关联。
J Clin Pharmacol. 2021 Dec;61(12):1592-1605. doi: 10.1002/jcph.1932. Epub 2021 Jul 20.
6
Pharmacokinetics and Pharmacodynamics of Immediate- and Modified-Release Mycophenolic Acid Preparations in Healthy Beagle Dogs.速释和缓释麦考酚酸制剂在健康比格犬体内的药代动力学和药效学
Front Vet Sci. 2021 Jan 28;7:611404. doi: 10.3389/fvets.2020.611404. eCollection 2020.
7
Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.来自 CIMTRE 研究的肾移植患者血浆和细胞麦考酚酸的群体药代动力学模型。
Drugs R D. 2020 Dec;20(4):331-342. doi: 10.1007/s40268-020-00319-y.
8
Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients.蛋白结合对游离和总霉酚酸暴露量的影响：中国成年肾移植受者的群体药代动力学分析
Front Pharmacol. 2020 Mar 20;11:340. doi: 10.3389/fphar.2020.00340. eCollection 2020.
9
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation.肾移植后第一年静息和活化靶细胞群体中霉酚酸的药效学评估。
Br J Clin Pharmacol. 2020 Jun;86(6):1100-1112. doi: 10.1111/bcp.14218. Epub 2020 Feb 16.
10
Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention.优化肾移植受者麦考酚酸暴露：是时候进行目标浓度干预了。
Transplantation. 2019 Oct;103(10):2012-2030. doi: 10.1097/TP.0000000000002762.